Intelligence Β· Patent portfolio

ENANTA PHARMACEUTICALS Patents

Full USPTO pharma patent portfolio for ENANTA PHARMACEUTICALS β€” grant dates, expiration, and drug cross-links.

Patents
218
Expiring ≀24m
9

Quick answer

ENANTA PHARMACEUTICALS has 218 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months β€” use filters for patent-cliff planning.

Page 1 of 5

  1. US 12384753

    17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12358921

    Antiviral heterocyclic compounds

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12297209

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 12281140

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 12268694

    Combination pharmaceutical agents as RSV inhibitors

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 12264159

    Functionalized heterocycles as antiviral agents

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 12162857

    Antiviral compounds

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 12145941

    Heterocyclic antiviral agents

    Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 12054493

    Hepatitis B antiviral agents

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 12018017

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 12011425

    Hepatitis B antiviral agents

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 11993600

    Saturated spirocyclics as antiviral agents

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 11970502

    Macrocyclic antiviral agents

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 11958879

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 11952389

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 11945824

    Heterocyclic compounds as anti-viral agents

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 11945830

    Antiviral heterocyclic compounds

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 11919910

    Spiropyrrolidine derived antiviral agents

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 11912714

    Spiropyrrolidine derived antiviral agents

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 11912695

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 11891393

    Functionalized heterocycles as antiviral agents

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 11834436

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 11760755

    Hepatitis B antiviral agents

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 11738019

    Substituted heterocycles as antiviral agents

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 11718641

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 11596611

    Hepatitis B antiviral agents

    Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 11572367

    Antiviral heterocyclic compounds

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 11560368

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 11534439

    Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 11472808

    Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 11420976

    Heterocyclic compounds as anti-viral agents

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 11390631

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 11377450

    Functionalized heterocycles as antiviral agents

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 11358953

    Functionalized peptides as antiviral agents

    Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 11352363

    Spiropyrrolidine derived antiviral agents

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 11339170

    Spiropyrrolidine derived antiviral agents

    Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 11325916

    Spiropyrrolidine derived antiviral agents

    Expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 11254664

    Benzodiazepine derivatives as RSV inhibitors

    Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 11236111

    Hepatitis B antiviral agents

    Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 11198693

    Functionalized heterocycles as antiviral agents

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 11179400

    Heterocyclic compounds as RSV inhibitors

    Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 11091501

    Heterocyclic compounds as RSV inhibitors

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 11058678

    Substituted heterocycles as antiviral agents

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 11040998

    Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 11034684

    Isoxazole analogs as FXR agonists and methods of use thereof

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 11008304

    Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 10988458

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 10975094

    Heterocyclic compounds as RSV inhibitors

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ENANTA PHARMACEUTICALS have?

218 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ENANTA PHARMACEUTICALS patents expire?

9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory